Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Treatment crawled date : 2022 - 10 - 25 save search
U.S. FDA Approves TECVAYLI™ (teclistamab-cqyv), the First Bispecific T-cell Engager Antibody for the Treatment of Patients with Relapsed or Refractory Multiple Myeloma
Published: 2022-10-25 (Crawled : 22:00) - biospace.com/
JNJ | $147.59 0.05% 0.0% 8.5M
|
Health Technology
|
| O: -0.06%
H: 0.0%
C: 0.0%
treatment fda antibody t-cell
Corvus Pharmaceuticals Announces Initiation of Phase 1b/2 Clinical Trial of Ciforadenant as Potential First Line Treatment for Patients with Renal Cell Cancer
Published: 2022-10-25 (Crawled : 20:00) - globenewswire.com
CRVS | $1.53 -1.96% 69K
|
Health Technology
|
| O: 3.56%
H: 2.67%
C: -3.51%
treatment pharmaceuticals renal trial potential cancer phase 2b
CADIZ INC. ANNOUNCES AGREEMENT TO ACQUIRE WATER TREATMENT TECHNOLOGY COMPANY ATEC SYSTEMS
Published: 2022-10-25 (Crawled : 17:00) - prnewswire.com
CDZI | $2.26 -2.59% -2.65% 120K
|
Utilities
|
| O: 0.0%
H: 26.11%
C: 14.01%
water treatment acquire technology agreement
ViiV Healthcare presents positive proof-of-concept findings for N6LS, an investigational, broadly neutralising antibody (bNAb) offering a potential new approach for the treatment of HIV
Published: 2022-10-25 (Crawled : 15:20) - biospace.com/
GLAXF | $20.07 -14.18% 1K
|
Health Technology
|
| O: 5.27%
H: 0.0%
C: -2.17%
PFE A | $25.91 0.19% -0.04% 34M
|
Health Technology
|
| O: -0.59%
H: 1.21%
C: 0.71%
GSK | $40.5 -0.39% -0.03% 2.8M
|
Health Technology
|
| O: 0.57%
H: 1.16%
C: 0.94%
offering treatment antibody hiv potential positive
Published Data Demonstrate Consistent PUL Outcomes for the Treatment of Median Lobe Obstruction Across Controlled and Real-World Settings
Published: 2022-10-25 (Crawled : 11:00) - globenewswire.com
TFX | $210.66 -1.76% 0.0% 290K
|
Health Technology
|
| O: -0.2%
H: 4.41%
C: 4.3%
treatment
Gainers vs Losers
| 49% | 51% |
Top 10 Gainers
KAVL | $6.275 135.02% 57.45% 44M
|
Wholesale Trade
PXMD | $0.7375 79.09% 44.16% 4.5M
|
Health Technology
DYNT | $0.371 -5.12% 43.09% 3.3M
|
Health Technology
LGVN P 3 d | $2.94 73.96% 42.52% 57M
|
HUBC | $1.94 49.23% 32.99% 73M
|
n/a
SPCB | $0.4044 46.52% 31.75% 130M
|
Electronic Technology
ONVO | $1.34 32.66% 24.62% 54M
|
Health Technology
OMQS | $0.6869 32.1% 24.3% 3.6M
|
Professional, Scientific, and T...
SNPO | $10.555 29.67% 22.88% 4M
|
AMBI | $3.72 -26.77% 21.77% 9.8K
|
n/a
Your saved searches
Save your searches and get alerts when important news are released.